Skip to main navigation
ANI Pharmaceuticals, Inc.
  • About
    Executive Team Board of Directors Purpose & Values
    How We Operate
    Quality Capabilities
    News
  • Products
  • Investors
  • We're Hiring
    We're Hiring Career Benefits Job Openings Employment Application Exploring Life in Baudette, MN
  • Contact
    Contact Us Locations

News

Investors Menu
  • Overview
  • News
  • Events & Presentations
  • Stock Information
    Stock Quote & Chart Investment Calculator Analyst Coverage
  • Financials
    Quarterly Results Annual Reports SEC Filings
  • Governance
    Governance Documents Executive Team Board of Directors Committee Composition
  • Resources
    Investor FAQs Information Request Form Investor Email Alerts Investor Contacts
01/02/2025
ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity

Contact Us

INVESTOR CONTACT

In-Site Communications, Inc.
Lisa M. Wilson

212-452-2793
envelope iconIR@anipharmaceuticals.com

Quick Links

  • SEC Filings
  • Investor FAQs
  • Information Request Form
Unsubscribe
ANI Pharmaceuticals, Inc.
Products | Investors | Careers | Contact Us | Privacy Policy | Terms of Use | Accessibility
© Copyright 2025 ANI Pharmaceuticals, Inc.
Linkedin Youtube